Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 May;13(5):836-41.
doi: 10.1016/j.cgh.2014.02.027. Epub 2014 Feb 28.

Acute-on-chronic liver failure: a new clinical entity

Richard Moreau  1 , Vicente Arroyo  2
Affiliations

Acute-on-chronic liver failure: a new clinical entity

Richard Moreau et al. Clin Gastroenterol Hepatol. 2015 May.

Abstract

Patients hospitalized for an acute complication of cirrhosis who also have organ failure(s) are at high risk of short-term death. The term acute-on-chronic liver failure (ACLF) is used to characterize these patients. Until recently, there was no evidence-based definition of ACLF. The results of a large prospective observational European study called Chronic Liver Failure Consortium Acute-on-Chronic Liver Failure in Cirrhosis study were published in 2013 establishing diagnostic criteria for ACLF in a large series of hospitalized patients who had an acute complication of cirrhosis. In addition, this study described the natural history of ACLF. According to the Acute-on-Chronic Liver Failure in Cirrhosis study, ACLF is now considered a new clinical entity because it is distinct from traditional decompensated cirrhosis, based not only on the presence of organ failure(s) and high mortality rate but also on younger age, alcoholic etiology of cirrhosis, higher prevalence of some precipitating events (bacterial infections, active alcoholism), and higher level of systemic inflammation. ACLF is a new entity also because it cannot be explained entirely by severe sepsis or severe alcoholic hepatitis; a large proportion of cases are of unknown origin. ACLF should be considered as a whole that includes subcategories such as severe sepsis, severe alcoholic hepatitis, and others, which have yet to be defined. ACLF is a relatively common syndrome because it occurs in 31% of hospitalized patients with cirrhosis who have an acute complication of their liver disease. In these patients, ACLF is the most common cause of death.

Keywords: Acute Decompensation; Cirrhosis; Organ Failures; Prognosis.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • Role of systemic inflammation in cirrhosis: From pathogenesis to prognosis.
    Dirchwolf M, Ruf AE. Dirchwolf M, et al. World J Hepatol. 2015 Aug 8;7(16):1974-81. doi: 10.4254/wjh.v7.i16.1974. World J Hepatol. 2015. PMID: 26261687 Free PMC article.
  • Characteristics and risk factors of urinary tract infection in patients with HBV-related acute-on-chronic liver failure: A retrospective study.
    Zhang Q, Shi B, Wu L. Zhang Q, et al. Medicine (Baltimore). 2022 Jul 15;101(28):e29913. doi: 10.1097/MD.0000000000029913. Medicine (Baltimore). 2022. PMID: 35839063 Free PMC article.
  • Practical Concerns and Controversies in the Management of Alcoholic Hepatitis.
    Im GY, Lucey MR. Im GY, et al. Gastroenterol Hepatol (N Y). 2016 Aug;12(8):478-489. Gastroenterol Hepatol (N Y). 2016. PMID: 27917083 Free PMC article.
  • Cirrhotic Multiorgan Syndrome.
    Møller S, Bendtsen F. Møller S, et al. Dig Dis Sci. 2015 Nov;60(11):3209-25. doi: 10.1007/s10620-015-3752-3. Epub 2015 Jun 26. Dig Dis Sci. 2015. PMID: 26112989 Review.
  • Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update.
    Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, Saigal S, Saraf N, Soin AS, Devarbhavi H, Kim DJ, Dhiman RK, Duseja A, Taneja S, Eapen CE, Goel A, Ning Q, Chen T, Ma K, Duan Z, Yu C, Treeprasertsuk S, Hamid SS, Butt AS, Jafri W, Shukla A, Saraswat V, Tan SS, Sood A, Midha V, Goyal O, Ghazinyan H, Arora A, Hu J, Sahu M, Rao PN, Lee GH, Lim SG, Lesmana LA, Lesmana CR, Shah S, Prasad VGM, Payawal DA, Abbas Z, Dokmeci AK, Sollano JD, Carpio G, Shresta A, Lau GK, Fazal Karim M, Shiha G, Gani R, Kalista KF, Yuen MF, Alam S, Khanna R, Sood V, Lal BB, Pamecha V, Jindal A, Rajan V, Arora V, Yokosuka O, Niriella MA, Li H, Qi X, Tanaka A, Mochida S, Chaudhuri DR, Gane E, Win KM, Chen WT, Rela M, Kapoor D, Rastogi A, Kale P, Rastogi A, Sharma CB, Bajpai M, Singh V, Premkumar M, Maharashi S, Olithselvan A, Philips CA, Srivastava A, Yachha SK, Wani ZA, Thapa BR, Saraya A, Shalimar, Kumar A, Wadhawan M, Gupta S, Madan K, Sakhuja P, Vij V, Sharma BC, Garg H, Garg V, Kalal C, Anand L, Vyas T, Mathur RP, Kumar G, Jain P, Pasupuleti SSR, Chawla YK, Chowdhury A, Alam S, Song DS, Yang JM, Yoon EL; APASL ACLF Research Consortium (AARC) for APASL ACLF working Party.. Sarin SK, et al. Hepatol Int. 2019 Jul;13(4):353-390. doi: 10.1007/s12072-019-09946-3. Epub 2019 Jun 6. Hepatol Int. 2019. PMID: 31172417 Free PMC article.
See all "Cited by" articles

LinkOut - more resources